Massive boost for Irish shares
The ISEQ started the day with a total value of just over 53.03 billion and closed the session at €54.36 billion.
Elan, which still has a major restructuring plan hanging over its head, got the year off to a positive start with some positive early trial results for its collaboration with Biogen on a drug to treat multiple sclerosis and Crohn’s disease.





